Erik Ahlstrand

Artiklar i tidskrifter

• Silfverberg, T. , Zjukovskaja, C. , Ljungman, P. , Nahimi, A. , Ahlstrand, E. , Dreimane, A. , Einarsdottir, S. , Fagius, J. & et al. (2024). Haematopoietic stem cell transplantation for treatment of relapsing-remitting multiple sclerosis in Sweden: an observational cohort study. Journal of Neurology, Neurosurgery and Psychiatry, 95 (2), 125-133.
• Flygt, H. , Söderlund, S. , Richter, J. , Saussele, S. , Koskenvesa, P. , Stenke, L. , Mustjoki, S. , Dimitrijevic, A. & et al. (2024). Treatment-free remission after a second TKI discontinuation attempt in patients with Chronic Myeloid Leukemia re-treated with dasatinib - interim results from the DAstop2 trial. Leukemia, 38 (4), 781-787.
• Ingberg, E. , Ahlstrand, E. , Cajander, P. , Löf, E. , Sundqvist, M. , Wegener, M. , Lidén, M. & Cajander, S. (2022). RT-PCR cycle threshold value in combination with visual scoring of chest computed tomography at hospital admission predicts outcome in COVID-19. Infectious Diseases, 54 (6), 431-440.
• Lindgren, M. , Andréasson, B. , Samuelsson, J. , Pettersson, H. , Enblom-Larsson, A. , Ravn-Landtblom, A. , Scheding, S. , Bentham, C. & et al. (2022). Survival and Risk of Vascular Complications in Myelofibrosis: A Population-Based Study from the Swedish MPN Group. European Journal of Haematology, 109 (4), 336-342.
• Richter, J. , Lübking, A. , Söderlund, S. , Lotfi, K. , Markevärn, B. , Själander, A. , Stenke, L. , Deneberg, S. & et al. (2021). Molecular status 36 months after TKI discontinuation in CML is highly predictive for subsequent loss of MMR-final report from AFTER-SKI. Leukemia, 35 (8), 2416-2418.
• Ahlstrand, E. , Cajander, S. , Cajander, P. , Ingberg, E. , Löf, E. , Wegener, M. & Lidén, M. (2021). Visual scoring of chest CT at hospital admission predicts hospitalization time and intensive care admission in Covid-19. Infectious Diseases, 53 (8), 622-632.
• Ahlstrand, E. , Samuelsson, J. , Lindgren, M. , Pettersson, H. , Liljeholm, M. , Ravn-Landtblom, A. , Scheding, S. & Andréasson, B. (2020). Highly Reduced Survival in Essential Thrombocythemia and Polycythemia Vera Patients with Vascular Complications during Follow-up. European Journal of Haematology, 104 (3), 271-278.
• Birgegard, G. , Samuelsson, J. , Ahlstrand, E. , Ejerblad, E. , Enevold, C. , Ghanima, W. , Hasselbalch, H. , Nielsen, C. H. & et al. (2019). Inflammatory functional iron deficiency common in myelofibrosis, contributes to anaemia and impairs quality of life. From the Nordic MPN study Group. European Journal of Haematology, 102 (3), 235-240.
• Löf, L. , Arngården, L. , Olsson-Strömberg, U. , Siart, B. , Jansson, M. , Dahlin, J. S. , Thörn, I. , Christiansson, L. & et al. (2017). Flow Cytometric Measurement of Blood Cells with BCR-ABL1 Fusion Protein in Chronic Myeloid Leukemia. Scientific Reports, 7 (1).
• Andersen, C. L. , Bjorn, M. E. , McMullin, M. F. , Harrison, C. , Samuelsson, J. , Ejerblad, E. , Zweegman, S. , Fernandes, S. & et al. (2014). Circulating YKL-40 in patients with essential thrombocythemia and polycythemia vera treated with the novel histone deacetylase inhibitor vorinostat. Leukemia research: a Forum for Studies on Leukemia and Normal Hemopoiesis, 38 (7), 816-821.
• Ahlstrand, E. , Bäckman, A. , Persson, L. , Mölling, P. , Tidefelt, U. & Söderquist, B. (2014). Evaluation of a PCR method to determine the clinical significance of blood cultures with Staphylococcus epidermidis in patients with hematological malignancies. Acta Pathologica, Microbiologica et Immunologica Scandinavica (APMIS), 122 (6), 539-544.
• Ahlstrand, E. , Hellmark, B. , Svensson, K. & Söderquist, B. (2014). Long-term molecular epidemiology of staphylococcus epidermidis blood culture isolates from patients with hematological malignancies. PLOS ONE, 9 (6).
• Andersen, C. L. , McMullin, M. F. , Ejerblad, E. , Zweegman, S. , Harrison, C. , Fernandes, S. , Bareford, D. , Knapper, S. & et al. (2013). A phase II study of vorinostat (MK-0683) in patients with polycythaemia vera and essential thrombocythaemia. British Journal of Haematology, 162 (4), 498-508.
• Ahlstrand, E. , Persson, L. , Tidefelt, U. & Söderquist, B. (2012). Alteration of the colonization pattern of coagulase-negative staphylococci in patients undergoing treatment for hematological malignancy. European Journal of Clinical Microbiology and Infectious Diseases, 31 (7), 1679-1687.
• Ahlstrand, E. , Svensson, K. , Persson, L. , Tidefelt, U. & Söderquist, B. (2011). Glycopeptide resistance in coagulase-negative staphylococci isolated in blood cultures from patients with hematological malignancies during three decades. European Journal of Clinical Microbiology and Infectious Diseases, 30 (11), 1349-1354.
• Granseth, B. , Ahlstrand, E. & Lindström, S. (2002). Paired pulse facilitation of corticogeniculate EPSCs in the dorsal lateral geniculate nucleus of the rat investigated in vitro. Journal of Physiology, 544 (2), 477-486.

Doktorsavhandlingar, sammanläggningar

• Ahlstrand, E. (2013). Coagulase-negative staphylococci in hematological malignancy. (Doctoral dissertation). (Sammanläggning) Örebro: Örebro universitet.

Konferensbidrag

• Åström, M. , Welander, E. , Pourlotfi, A. , Abawi, A. , Ahlstrand, E. & Ivarsson, M. (2018). Activated interferon signaling in cultured BMSC from myelofibrosis patients: core finding of a proteomic study.  Konferensbidrag vid 2nd International Conference on Tissue Repair, Regeneration, and Fibrosis, Chania, Crete, Greece, June 13-16, 2018.
• Welander, E. , Åström, M. , Enonge Fotabe, L. , Kardeby, C. , Tina, E. , Elgbratt, K. , Pourlotfi, A. , Abawi, A. & et al. (2018). Integrated analysis indicates reciprocal immune response dysregulations between bone marrow multipotent stromal cells and granulocytes at the mRNA but not at the protein level in myelofibrosis.  Konferensbidrag vid Fortbildningsdagar i hematologi, Umeå, 3-5 Oktober, 2018.

Manuskript

• Ahlstrand, E. , Hellmark, B. , Svensson, K. & Söderquist, B. Long-term molecular epidemiology of Staphylococcus epidermidis blood culture isolates from patients with haematological malignancies.